Effects of Unani Formulation In Patients With Chronic Bronchitis
Phase 3
- Conditions
- Health Condition 1: J410- Simple chronic bronchitis
- Registration Number
- CTRI/2023/11/059830
- Lead Sponsor
- Dr Neha Fathima
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either sex
2. Patients of age between 35-60 years
3. Patients with productive cough for more than 3 weeks
4. Patients having breathlessness
Exclusion Criteria
1. Pregnant and Lactating Females
2. Uncontrolled Hypertension
3. Diabetic patients
4. Bronchial Asthma
5. Tuberculosis
6. Acute Respiratory In fections
7. Lung carcinoma
8. Pneumonia
9. Heart diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome depends on Relief in cough, sputum production and breathlessness As per BCSS (Breathlessness, Cough and Sputum production Scale) before and after treatment/interventionTimepoint: It can be assessed within the time period of 6 weeks.
- Secondary Outcome Measures
Name Time Method Depends on the relief in nature of disease, preventing recurrent respiratory infectionsTimepoint: Outcome will be assessed at 6th week